Keywords: Alcon, ESBATech, mergers and acquisitions, ophthalmology

Alcon to acquire Swiss biotech ESBATech for up to $439 million

Article | 14 September 2009

Print This

Switzerland’s Alcon has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. Alcon will pay ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in